Drug Database
Back to search

Netherlands· NL-d7caea68ee25

Acelyn 0,05 mg, tabletten

A ethinylestradiol product containing ethinylestradiol, registered in Netherlands by ACE Pharmaceuticals B.V.. The same ATC class is registered in 3 of our 19 countries.

ATC G03CA01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAcelyn 0,05 mg, tablettenATCG03CA01REGISTER NO.NL-d7caea68ee25PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ethinylestradiolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ethinylestradiol is registered in 3 of 19 countries.

Countries holding a registration under ATC G03CA01 (ethinylestradiol), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 2 of them publish a price we can compare per daily dose
Search ethinylestradiol products by name

Ethinylestradiol · ATC G03CA01

3 / 19 countries

  • Finlandprice
  • Netherlands
  • Norwayprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ETHINYLESTRADIOL
Manufacturer
ACE Pharmaceuticals B.V.
Country
Netherlands (NL)
ATC code
G03CA01
ATC class
Ethinylestradiol
Defined daily dose
25 mcg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    00022

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

463 interactions on record for ethinylestradiol.

Graded by severity as the source publishes them — 40 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ethinylestradiol against other medicinesHow interaction checks work

Ethinylestradiol · interactions on record

463 records

  • 40 severe
  • 372 moderate
  • 49 minor

Most severe, free to view

  • Tranexamic acidB02AA02severe
  • HeminB06AB01severe
  • BosentanC02KX01severe
  • GriseofulvinD01AA08severe

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ethinylestradiol in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ethinylestradiol products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • France · Ethinyloestradiol Effik

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a776f248-ab9c-4d5d-865f-4b923bfc5027
GET /v1/drugs/a776f248-ab9c-4d5d-865f-4b923bfc5027?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h00022_smpc.pdf",
  "strength": null,
  "atc_label": "Ethinylestradiol",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg00022",
  "excipients": [
    "INDIGOKARMIJN (E 132)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POTATO STARCH (RI)",
    "POVIDON (E 1201)",
    "SILICIUMDIOXIDE (E 551)"
  ],
  "substances": [
    "ETHINYLESTRADIOL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h00022.pdf",
  "authorised_at": "1990/05/20",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "00022",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about ethinylestradiol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console